VANDA PHARMACEUTICALS INC. Shares Outstanding (Cover Page)
VANDA PHARMACEUTICALS INC. (VNDA) had Shares Outstanding (Cover Page) of 60.46 million shares as of 2026-07-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-30: Entity Common Stock, Shares Outstanding 60.46M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 60.14M shares.
- 2026-02-05: Entity Common Stock, Shares Outstanding 59.11M shares.
- 2025-10-23: Entity Common Stock, Shares Outstanding 59.10M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-30 | 60.46M shares 10-Q · filed 2026-08-06 |
| 2026-04-30 | 60.14M shares 10-Q · filed 2026-05-07 |
| 2026-02-05 | 59.11M shares 10-K · filed 2026-02-12 |
| 2025-10-23 | 59.10M shares 10-Q · filed 2025-10-30 |
| 2025-07-24 | 59.09M shares 10-Q · filed 2025-07-31 |
| 2025-05-01 | 58.93M shares 10-Q · filed 2025-05-08 |
| 2025-02-07 | 58.32M shares 10-K · filed 2025-02-14 |
| 2024-10-31 | 58.31M shares 10-Q · filed 2024-11-07 |
| 2024-07-25 | 58.29M shares 10-Q · filed 2024-08-01 |
| 2024-05-02 | 58.20M shares 10-Q · filed 2024-05-09 |
| 2024-02-01 | 57.54M shares 10-K · filed 2024-02-08 |
| 2023-11-02 | 57.53M shares 10-Q · filed 2023-11-09 |
| 2023-07-20 | 57.51M shares 10-Q · filed 2023-07-28 |
| 2023-04-27 | 57.44M shares 10-Q · filed 2023-05-03 |
| 2023-02-02 | 56.79M shares 10-K · filed 2023-02-09 |
| 2022-10-27 | 56.59M shares 10-Q · filed 2022-11-03 |
| 2022-07-28 | 56.56M shares 10-Q · filed 2022-08-04 |
| 2022-04-29 | 56.49M shares 10-Q · filed 2022-05-06 |
| 2022-02-17 | 55.91M shares 10-K · filed 2022-02-24 |
| 2021-10-28 | 55.71M shares 10-Q · filed 2021-11-04 |
| 2021-07-22 | 55.64M shares 10-Q · filed 2021-07-29 |
| 2021-04-29 | 55.56M shares 10-Q · filed 2021-05-06 |
| 2021-02-04 | 54.88M shares 10-K · filed 2021-02-11 |
| 2020-10-22 | 54.69M shares 10-Q · filed 2020-10-29 |
| 2020-07-30 | 54.65M shares 10-Q · filed 2020-08-06 |
| 2020-04-30 | 54.55M shares 10-Q · filed 2020-05-07 |
| 2020-02-18 | 53.65M shares 10-K · filed 2020-02-26 |
| 2019-10-31 | 53.34M shares 10-Q · filed 2019-11-07 |
| 2019-07-25 | 53.27M shares 10-Q · filed 2019-08-01 |
| 2019-04-24 | 52.96M shares 10-Q · filed 2019-05-03 |
| 2019-02-12 | 52.64M shares 10-K · filed 2019-02-19 |
| 2018-10-25 | 52.45M shares 10-Q · filed 2018-11-07 |
| 2018-07-19 | 52.38M shares 10-Q · filed 2018-08-02 |
| 2018-04-19 | 52.11M shares 10-Q · filed 2018-05-02 |
| 2018-02-01 | 45.44M shares 10-K · filed 2018-02-15 |
| 2017-10-30 | 44.93M shares 10-Q · filed 2017-11-08 |
| 2017-07-26 | 44.86M shares 10-Q · filed 2017-08-03 |
| 2017-04-24 | 44.55M shares 10-Q · filed 2017-05-03 |
| 2017-02-06 | 44.35M shares 10-K · filed 2017-02-17 |
| 2016-10-24 | 43.95M shares 10-Q · filed 2016-11-03 |
| 2016-07-21 | 43.28M shares 10-Q · filed 2016-07-28 |
| 2016-04-30 | 43.15M shares 10-Q · filed 2016-05-05 |
| 2016-01-31 | 43.10M shares 10-K · filed 2016-02-12 |
| 2015-10-30 | 42.82M shares 10-Q · filed 2015-11-04 |
| 2015-07-24 | 42.29M shares 10-Q · filed 2015-07-31 |
| 2015-04-30 | 41.80M shares 10-Q · filed 2015-05-07 |
| 2015-03-06 | 41.64M shares 10-K · filed 2015-03-13 |
| 2014-10-22 | 33.90M shares 10-Q · filed 2014-10-27 |
| 2014-07-31 | 33.88M shares 10-Q · filed 2014-08-08 |
| 2014-04-30 | 33.87M shares 10-Q · filed 2014-05-08 |
| 2014-02-20 | 33.50M shares 10-K · filed 2014-02-25 |
| 2013-10-31 | 33.19M shares 10-Q · filed 2013-11-08 |
| 2013-07-26 | 28.48M shares 10-Q · filed 2013-07-31 |
| 2013-04-30 | 28.35M shares 10-Q · filed 2013-05-10 |
| 2013-02-20 | 28.34M shares 10-K · filed 2013-02-26 |
| 2012-11-05 | 28.23M shares 10-Q · filed 2012-11-08 |
| 2012-07-31 | 28.23M shares 10-Q · filed 2012-08-03 |
| 2012-05-04 | 28.23M shares 10-Q · filed 2012-05-09 |
| 2012-03-07 | 28.23M shares 10-K · filed 2012-03-09 |
| 2011-11-02 | 28.10M shares 10-Q · filed 2011-11-07 |
| 2011-08-02 | 28.10M shares 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |